课题基金 / 基金详情

Cell lineage-related mechanisms involved in lung cancer stem cell development.

Cell lineage-related mechanisms involved in lung cancer stem cell development.
肺癌干细胞发育中涉及的细胞谱系相关机制。
批准号:
23501281
负责人:
OSADA Hirotaka
金额:
$3.08万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2011
资助国家:
日本
项目状态:
已结题
起止时间:
2011 至 2013

项目摘要

项目成果

OSADA Hirotaka的其他基金

相似基金

相关文献

中文摘要
翻译
最初从几种不同的肺癌细胞系中建立了球体形成细胞,之后表达谱和肿瘤发生测定结果表明它们具有癌症干细胞特性。此外,这些细胞中神经内分泌相关基因的表达表明球体形成和细胞谱系可塑性之间可能存在关联。此外,神经内分泌诱导的ASH1也被发现在一些细胞系中促进球体形成,这表明ASH1信号转导参与了癌症干细胞的发育。
英文摘要
Sphere-forming cells were initially established from several different lung cancer cell lines, after which expression profiling and tumorigenesis assay findings indicated their cancer stem cell properties. In addition, expression of neuroendocrine-related genes in these cells suggests a possible association between sphere formation and cell lineage plasticity. Furthermore, neuroendocrine-inducing ASH1 has also been found to promote sphere formation in some cell lines, suggesting the involvement of ASH1 signaling in development of cancer stem cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The circadian clock gene BMAL1 is a novel therapeutic target for malignant mesothelioma
生物钟基因BMAL1是恶性间皮瘤的新治疗靶点
DOI: --
发表时间: 2012
期刊: Int J Cancer
影响因子: 6.4
作者: [Elshazley M, Sato M, Hase T, Takeyama Y, Yamashita R, Yoshida K, Toyokuni S, Ishiguro F, Osada H, Sekido Y, Yokoi K, Usami N, Shames DS, Kondo M, Gazdar AF, Minna JD, Hasegawa Y]
通讯作者: Hasegawa Y
miR-375 is activated by ASH1 and inhibits YAP1 in a lineage dependent manner in lung cancermiR-375 is activated by ASH1 and inhibits YAP1 in a lineage dependent manner in lung cancer
在肺癌中,miR-375 被 ASH1 激活,并以谱系依赖性方式抑制 YAP1 在肺癌中,miR-375 被 ASH1 激活,并以谱系依赖性方式抑制 YAP1
DOI: --
发表时间: 2011
期刊: Cancer Res
影响因子: 11.2
作者: [Nishikawa E, Osada H, Okazaki Y, Arima C, Tomida S, Tatematsu Y, Taguchi A, Shimada Y, Yanagisawa K, Yatabe Y, Toyokuni S, Sekido Y, Takahashi T]
通讯作者: Takahashi T
Epithelial to mesenchymal transition in an EGFR-mutant lung cancer cell line with acquired resistance to erlotinib
对厄洛替尼获得性耐药的 EGFR 突变肺癌细胞系的上皮细胞向间质细胞转变
DOI: --
发表时间: 2011
期刊: J Thorac Oncol
影响因子: 20.4
作者: [Suda K, Tomizawa K, Fujii M, Murakami H, Osada H, Maehara Y, Yatabe Y, Sekido Y, Mitsudomi T]
通讯作者: Mitsudomi T
DOI: --
发表时间: 2011
期刊:
影响因子: --
作者: [野村 幸世, 愛甲 丞, 大本 安一, 多田 稔, 大津 洋, 三浦 洋菜, 山形 幸徳, 瀬戸 泰之, 上西 紀夫, Mizuno T, 野村 幸世, Ishiguro F]
通讯作者: Ishiguro F
37
    Investigation of epigenetic abnormalities involved in lung cancer progression.
    • 批准号:
      20590324
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2008
    • 负责人:
      OSADA Hirotaka
    • 依托单位:
    Molecular mechanisms of associations between abnormal differentiation and altered regulations of gene expressions.
    • 批准号:
      18590308
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.44万
    • 财政年份:
      2006
    • 负责人:
      OSADA Hirotaka
    • 依托单位:
    Alterations of Genome Network Regulations and Chromatin Configurations related to Carcinogenesis
    • 批准号:
      16590258
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.24万
    • 财政年份:
      2004
    • 负责人:
      OSADA Hirotaka
    • 依托单位:
    The mechanism of apoptosis induction by TGF-β stimuli and its clinical application
    • 批准号:
      13670157
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.24万
    • 财政年份:
      2001
    • 负责人:
      OSADA Hirotaka
    • 依托单位:
    海外基金